PMVP
Price
$1.14
Change
-$0.01 (-0.88%)
Updated
Jan 15, 12:00 PM (EDT)
Capitalization
60.66M
48 days until earnings call
Intraday BUY SELL Signals
RGNX
Price
$14.60
Change
-$0.35 (-2.34%)
Updated
Jan 15, 12:05 PM (EDT)
Capitalization
756.82M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PMVP vs RGNX

Header iconPMVP vs RGNX Comparison
Open Charts PMVP vs RGNXBanner chart's image
PMV Pharmaceuticals
Price$1.14
Change-$0.01 (-0.88%)
Volume$100
Capitalization60.66M
REGENXBIO
Price$14.60
Change-$0.35 (-2.34%)
Volume$400
Capitalization756.82M
PMVP vs RGNX Comparison Chart in %
PMVP
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
PMVP vs. RGNX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMVP is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (PMVP: $1.14 vs. RGNX: $14.95)
Brand notoriety: PMVP and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMVP: 141% vs. RGNX: 79%
Market capitalization -- PMVP: $60.66M vs. RGNX: $756.82M
PMVP [@Biotechnology] is valued at $60.66M. RGNX’s [@Biotechnology] market capitalization is $756.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMVP’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • PMVP’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMVP’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • PMVP’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RGNX is a better buy in the short-term than PMVP.

Price Growth

PMVP (@Biotechnology) experienced а -7.69% price change this week, while RGNX (@Biotechnology) price change was -1.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

PMVP is expected to report earnings on Mar 04, 2026.

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($757M) has a higher market cap than PMVP($60.7M). RGNX YTD gains are higher at: 3.819 vs. PMVP (-8.800). PMVP has higher annual earnings (EBITDA): -91.99M vs. RGNX (-120M). RGNX has more cash in the bank: 274M vs. PMVP (129M). PMVP has less debt than RGNX: PMVP (931K) vs RGNX (76.5M). RGNX has higher revenues than PMVP: RGNX (161M) vs PMVP (0).
PMVPRGNXPMVP / RGNX
Capitalization60.7M757M8%
EBITDA-91.99M-120M77%
Gain YTD-8.8003.819-230%
P/E RatioN/AN/A-
Revenue0161M-
Total Cash129M274M47%
Total Debt931K76.5M1%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
22
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PMVPRGNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 21 days ago
76%
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
PMVP
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AZMIX21.180.20
+0.95%
Virtus NFJ Emerging Markets Value Ins
IIVAX27.080.20
+0.74%
Transamerica Small/Mid Cap Value A
TVOIX44.050.23
+0.52%
Touchstone Small Cap Value Institutional
MWEIX43.160.03
+0.07%
MFS Global Equity I
HGOTX78.44-1.12
-1.41%
Hartford Growth Opportunities R5

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with CLLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
-1.72%
CLLS - PMVP
39%
Loosely correlated
+0.47%
SYRE - PMVP
36%
Loosely correlated
+5.17%
MTVA - PMVP
35%
Loosely correlated
-30.06%
CMVLF - PMVP
34%
Loosely correlated
N/A
RGNX - PMVP
34%
Loosely correlated
-0.66%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-0.66%
SYRE - RGNX
56%
Loosely correlated
+5.17%
BEAM - RGNX
55%
Loosely correlated
+2.49%
VYGR - RGNX
55%
Loosely correlated
+2.74%
XNCR - RGNX
54%
Loosely correlated
+3.66%
DNLI - RGNX
52%
Loosely correlated
+0.88%
More